The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The study will investigate the impact of reduced renal function on the pharmacokinetic and
pharmacodynamic profile of LEO 27847. Volunteers with different degrees of renal impairment
will be administered one dose of the investigational drug and then followed until
investigational drug is eliminated from the body.